|
TCHP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.070400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.307800E-01 |
| Normal-vs-Stage2 |
5.981800E-01 |
| Normal-vs-Stage3 |
1.709780E-01 |
| Normal-vs-Stage4 |
5.487600E-01 |
| Stage1-vs-Stage2 |
7.204600E-01 |
| Stage1-vs-Stage3 |
1.890420E-01 |
| Stage1-vs-Stage4 |
6.644200E-01 |
| Stage2-vs-Stage3 |
5.911800E-01 |
| Stage2-vs-Stage4 |
9.860400E-01 |
| Stage3-vs-Stage4 |
5.685600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.863000E-01 |
| Normal-vs-AfricanAmerican |
7.043200E-01 |
| Normal-vs-Asian |
3.123800E-01 |
| Caucasian-vs-AfricanAmerican |
2.339000E-01 |
| Caucasian-vs-Asian |
2.760200E-01 |
| AfricanAmerican-vs-Asian |
5.702800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.661500E-02 |
| Normal-vs-Female |
2.171800E-01 |
| Male-vs-Female |
1.026930E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.221600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.872200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.193800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.704800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.050380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.588350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.289000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.852000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.427600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.024200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.638600E-01 |
| Normal-vs-Grade 2 |
8.363000E-01 |
| Normal-vs-Grade 3 |
3.031200E-01 |
| Normal-vs-Grade 4 |
6.679600E-02 |
| Grade 1-vs-Grade 2 |
2.467600E-01 |
| Grade 1-vs-Grade 3 |
1.577200E-01 |
| Grade 1-vs-Grade 4 |
5.535600E-02 |
| Grade 2-vs-Grade 3 |
3.206200E-01 |
| Grade 2-vs-Grade 4 |
6.468100E-02 |
| Grade 3-vs-Grade 4 |
3.017600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.321200E-01 |
| Normal-vs-ccB subtype |
1.220090E-02 |
| ccA subtype-vs-ccB subtype |
1.835310E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.544800E-01 |
| Normal-vs-N1 |
9.003000E-01 |
| N0-vs-N1 |
8.062800E-01 |
|
|
